Mark J. Greenwald
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mark J. Greenwald has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ann Carroll
Independent Researcher, Roseville, MN 55113, USA
1 shared publication - Anna L. Ells
Dept of Computing and Software University of Calgary Alberta Canada
1 shared publication - Clio Armitage Harper
University of Texas Health San Antonio
1 shared publication - Erima Denis
Lubaga Hospital, Kampala P.O. Box 14130, Uganda
1 shared publication - Lucy Namakula
St. Francis Hospital Nsambya, Kampala P.O. Box 7146, Uganda
1 shared publication - Maria Ana Martinez-Castellanos
Asociación para Evitar la Ceguera en México, Mexico City, Mexico
1 shared publication
Latest Publications
- Open Access
- 3 February 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (3) , 1228
Retinopathy of Prematurity in the 21st Century and the Complex Impact of Supplemental Oxygen
Retinopathy of prematurity (ROP) is a leading cause of childhood blindness. Not only do the epidemiologic determinants and distributions of patients with ROP vary worldwide, but clinical differences have also been described. The Third Edition of the International Classification of ROP (ICROP3) acknowledges that aggressive ROP (AROP) can occur in larger preterm infants and involve areas of the more anterior retina, particularly in low-resource settings with unmonitored oxygen supplementation. As sub-specialty training programs are underway to address an epidemic of ROP in sub-Saharan Africa, recognizing characteristic retinal pathology in preterm infants exposed to unmonitored supplemental oxygen is important to proper diagnosis and treatment. This paper describes specific features associated with various ROP presentations: oxygen-induced retinopathy in animal models, traditional ROP seen in high-income countries with modern oxygen management, and ROP related to excessive oxygen supplementation in low- and middle-income countries: oxygen-associated ROP (OA-ROP).
- 3 February 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (3) , 1228
Open AccessRetinopathy of Prematurity in the 21st Century and the Complex Impact of Supplemental Oxygen
Retinopathy of prematurity (ROP) is a leading cause of childhood blindness. Not only do the epidemiologic determinants and distributions of patients with ROP vary worldwide, but clinical differences have also been described. The Third Edition of the International Classification of ROP (ICROP3) acknowledges that aggressive ROP (AROP) can occur in larger preterm infants and involve areas of the more anterior retina, particularly in low-resource settings with unmonitored oxygen supplementation. As sub-specialty training programs are underway to address an epidemic of ROP in sub-Saharan Africa, recognizing characteristic retinal pathology in preterm infants exposed to unmonitored supplemental oxygen is important to proper diagnosis and treatment. This paper describes specific features associated with various ROP presentations: oxygen-induced retinopathy in animal models, traditional ROP seen in high-income countries with modern oxygen management, and ROP related to excessive oxygen supplementation in low- and middle-income countries: oxygen-associated ROP (OA-ROP).